While dressing acquisition cost is often a consideration when selecting wound care products, clinicians increasingly recognise that the true cost of wound management extends beyond the price of the dressing itself.
For hard-to-heal wounds, factors such as healing time, nursing visits, dressing changes, complications, and patient quality of life can significantly influence overall treatment costs.
In this NHS Drug Tariff comparison, MedCu is lower cost than Aquacel Ag+ Extra across all comparable size bands analysed.
This article explores the available evidence on copper dressings versus silver dressings, and the broader economics of wound care.
The purchase price of a wound dressing represents only one component of wound management costs.
In practice, overall costs may include:
As a result, a dressing with a higher acquisition cost may still be cost effective if it supports faster healing or reduces overall resource use.
For many chronic wounds, the greatest costs are associated with prolonged treatment rather than the dressing itself.
Hard-to-heal wounds may require:
Reducing healing time can therefore have a significant impact on total treatment costs.
The table below compares NHS Drug Tariff pricing for Aquacel Ag+ Extra (silver dressing) against MEDCu (copper dressing equivalent pricing).
|
Size |
Aquacel Ag+ Extra |
MEDCu Copper |
Saving |
|---|---|---|---|
|
5cm x 5cm |
£2.21 |
£1.88 |
£0.33 |
|
10cm x 10cm |
£5.26 |
£4.63 |
£0.63 |
|
10cm x 20cm |
£9.93 |
£7.07 |
£2.86 |
|
20cm x 20cm |
£24.63 |
£14.04 |
£10.59 |
Pricing based on NHS Drug Tariff (June 2026).
Across all comparable size bands:
Clinical studies suggest that chronic wound healing is strongly linked to overall resource use, particularly where wounds fail to progress despite standard care.
In a prospective single-arm study (Gorel et al., 2023), wounds that had previously responded poorly to silver dressings showed improved healing progression following the introduction of copper dressings.
In addition, a case series by Karpeniuk et al. (2025) reported rapid improvement in hard-to-heal venous leg ulcers, with most wounds achieving closure within approximately 9.6 weeks following copper dressing use.
A separate clinical evaluation (Dhoonmoon, 2025) reported improved wound healing outcomes alongside reduced overall treatment costs, with a mean cost reduction from £2,606 (standard care) to £365 following copper dressing use. This reduction was associated with faster healing and reduced nursing resource requirements.
Delayed wound healing is a major driver of NHS resource utilisation.
Potential impacts include:
Across published studies, copper dressings have been associated with improved healing progression and wound bed improvement, which may contribute to reduced overall treatment burden.
Copper and silver dressings should not be viewed as direct replacements in all cases.
Silver dressings continue to play an important role in antimicrobial management, particularly in acute or heavily bioburdened wounds.
However, evidence suggests copper dressings may offer benefits in some hard-to-heal wounds, particularly where healing has stalled despite previous antimicrobial therapy.
Clinical selection should always consider:
Rather than focusing solely on unit price, clinicians and procurement teams may wish to consider:
This broader approach provides a more accurate assessment of value in wound management.
Gorel O. et al. (2023). Enhanced healing of wounds that responded poorly to silver dressing by copper wound dressings: Prospective single-arm treatment study. Health Science Reports, 7(1):e1816.
Dhoonmoon L. (2025). Healing hard-to-heal wounds and improving quality of life. Journal of Community Nursing, 39(5), 28–33.
Karpeniuk S. et al. (2025). Effective Management of Venous Leg Ulcers by Copper Dressings. International Journal of Clinical Case Reports and Reviews, 31(1).